Regulatory News
Friday, April 15, 2016
U.S. FDA rejects Chiasma's drug to treat growth disorder
April 15 (Reuters) - The U.S. Food and Drug Administration
on Friday rejected Chiasma Inc's drug to treat adults
with a type of growth disorder.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment